Lori J. Braender, Chief Legal Officer at Aquestive Therapeutics ($AQST), made one open market sale of common shares in the last 365 days, totaling $167,346. Her most recent sale occurred on March 10, 2026. These AQST insider sales rank 8,789th among 11,678 individual insiders in our database, where the average sale amount is $8.6 million across about 6.4 transactions. Braender made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Aquestive Therapeutics, Inc. | $AQST | BRAENDER LORI J | Chief Legal Officer | A | Non-Qualified Stock Option (right to buy) | 50000 | $4.29 | 50,000.0000 | 122,003,113 | 9999.99% | 0.04% |
| March 10, 2026 | Aquestive Therapeutics, Inc. | $AQST | BRAENDER LORI J | Chief Legal Officer | S | Common Stock | 40102 | $4.17 | 442,879.0000 | 122,003,113 | 8.30% | 0.03% |
| March 9, 2026 | Aquestive Therapeutics, Inc. | $AQST | BRAENDER LORI J | Chief Legal Officer | A | Common Stock | 80000 | $0.00 | 482,981.0000 | 122,003,113 | 19.85% | 0.07% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | BRAENDER LORI J | Chief Legal Officer | A | Non-Qualified Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 98,871,369 | 9999.99% | 0.06% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | BRAENDER LORI J | Chief Legal Officer | A | Common Stock | 110000 | $0.00 | 423,231.0000 | 98,871,369 | 35.12% | 0.11% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | BRAENDER LORI J | Chief Legal Officer | F | Common Stock | 9592 | $2.65 | 413,639.0000 | 98,871,369 | 2.27% | 0.01% |
| March 9, 2025 | Aquestive Therapeutics, Inc. | $AQST | BRAENDER LORI J | Chief Legal Officer | F | Common Stock | 10658 | $2.65 | 402,981.0000 | 98,871,369 | 2.58% | 0.01% |
| March 9, 2024 | Aquestive Therapeutics, Inc. | $AQST | BRAENDER LORI J | SVP, General Counsel | F | Common Stock | 10530 | $4.88 | 313,231.0000 | 0 | 3.25% | 0.00% |
| March 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | BRAENDER LORI J | SVP, General Counsel | A | Non-Qualified Stock Option (right to buy) | 67500 | $0.00 | 67,500.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | BRAENDER LORI J | SVP, General Counsel | A | Common Stock | 135000 | $0.00 | 323,761.0000 | 0 | 71.52% | 0.00% |